Clinical Trial Update: Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase I/Phase II randomized trial evaluated second-line therapy for colorectal cancer using irinotecan and cetuximab with or without RAD001 (ever…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Afinitor (everolimus)
• Camptosar (irinotecan)
• ERBITUX (cetuximab)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED